+213,541.0%
NVDA vs CME
+7,469.3%
+206,071.7%
-85.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CME | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.8% | -0.3% | +1.1% | +0.9% |
| 7D | +5.9% | -1.6% | +7.5% | +6.5% |
| 30D | +5.1% | +6.2% | -1.2% | +2.3% |
| 3M | +5.4% | +10.4% | -5.1% | +0.3% |
| 6M | +26.0% | -9.5% | +35.5% | +29.4% |
| YTD | +23.7% | +6.0% | +17.7% | +18.4% |
| 1Y | +34.4% | +9.3% | +25.1% | +26.4% |
| 3Y | +375.8% | +57.7% | +318.1% | +270.2% |
| 5Y | +911.8% | +77.7% | +834.1% | +648.3% |
| 10Y | +14,899.8% | +281.2% | +14,618.6% | +7,495.6% |
| All | +213,541.0% | +7,469.3% | +206,071.7% | +31,575.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CME.
Daily Out/Under-Performance
Portfolio return minus CME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling